FDA Approvals - SEC adds insider trading charge vs FDA chemistFederal regulators on
SEC adds insider trading charge vs FDA chemist
Federal regulators on Thursday expanded their civil insider-trading charges against a chemist with the Food and Drug Administration accused of using confidential FDA information on pending drug approvals to profit from trades of drug companies' stock.